Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01905345
Other study ID # REGPOT
Secondary ID
Status Completed
Phase N/A
First received July 16, 2013
Last updated August 4, 2017
Start date August 2013
Est. completion date August 2017

Study information

Verified date August 2017
Source University of Zurich
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Randomised training intervention.

Influence of consecutive training regime on the impact of the myonuclear domain and satellite cell

Sarcopenia

Despite that the muscle mass can be positively influenced by training, the loading with high weights and/or to the total exhaustion is for many old persons not possible.

Therefore we aim to enhance the myonuclei in the muscle fiber of old male subjects in a first phase by endurance training, in order to promote a more effective muscle growth in a second phase by resistance exercise.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date August 2017
Est. primary completion date December 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 75 Years
Eligibility Inclusion criteria: -male

- no fever at the beginning and during the study

- between 60 years and 75 years

- non smokers

- no known cardiovascular and orthopaedic problems

- no cardiac pacemaker

- fulfilling the health criteria

Exclusion criteria: -female

- fever or cold at the beginning or during the study

- non MRI compatible metal implants

- under 60 years or over 75 years

- smoker

- cardiovascular or orthopaedic problems

- cardiac pacemaker

- not fulfilling the health criteria

Study Design


Related Conditions & MeSH terms

  • Regeneration Potential of Healthy Old Men in Terms of Satellite Cell Activation

Intervention

Procedure:
Training


Locations

Country Name City State
Switzerland University Hospital Zurich, Division of Neurology Zurich ZH

Sponsors (1)

Lead Sponsor Collaborator
University of Zurich

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Difference in % from baseline in fibre type specific number of satellite cells, fibre type specific myonuclear domain [um^2], myonuclear number [%] in response to consecutive training regimes Difference in % from baseline in fibre type specific number of satellite cells, fibre type specific myonuclear domain [um^2], myonuclear number [%] in response to consecutive training regimes participants will be followed for the duration of training period, an expected average of 7 months